Page 113 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 113
Study design in gut microbiome assessments Lehar 4
Stolz 1
7:30 - 8:30 Moderators: Stolz 2
Antonio Gasbarinni, Italy
Herbert Tilg, Austria Schubert 1
Schubert 2
Animal models of liver fibrosis Schubert 4 SCIENTIFIC PROGRAMME
7:30 - 8:30 Moderators: 113
Rabea Hall, Germany
Fiona Oakley, The United Kingdom
Metabolomic technologies and applications in liver disease
7:30 - 8:30 Moderators:
Jeff Idle, Switzerland
José Matos, Spain
Fatigue in chronic liver disease
7:30 - 8:30 Moderators:
David Jones, The United Kingdom
Aleksander Krag, Denmark
Acute on chronic liver failure: new definitions
7:30 - 8:30 Moderators:
Javier Fernandez, Spain
Claire Francoz, France
Antiviral Therapy in HIV-HCV coinfected patients
7:30 - 8:30 Moderators:
Raffael Bruno, Italy
Mattias Mandorfer, Austria
Vienna, Austria • April 22–26, 2015
Stolz 1
7:30 - 8:30 Moderators: Stolz 2
Antonio Gasbarinni, Italy
Herbert Tilg, Austria Schubert 1
Schubert 2
Animal models of liver fibrosis Schubert 4 SCIENTIFIC PROGRAMME
7:30 - 8:30 Moderators: 113
Rabea Hall, Germany
Fiona Oakley, The United Kingdom
Metabolomic technologies and applications in liver disease
7:30 - 8:30 Moderators:
Jeff Idle, Switzerland
José Matos, Spain
Fatigue in chronic liver disease
7:30 - 8:30 Moderators:
David Jones, The United Kingdom
Aleksander Krag, Denmark
Acute on chronic liver failure: new definitions
7:30 - 8:30 Moderators:
Javier Fernandez, Spain
Claire Francoz, France
Antiviral Therapy in HIV-HCV coinfected patients
7:30 - 8:30 Moderators:
Raffael Bruno, Italy
Mattias Mandorfer, Austria
Vienna, Austria • April 22–26, 2015